Institutional Profile

The International Society for Cellular Therapy: Evolving to meet the demands of the regenerative medicine industry

Richard Maziarz, Jane Arthurs, Edwin Horwitz

Research output: Contribution to journalArticle

Abstract

The International Society for Cellular Therapy is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Established in 1992, its membership and leadership comprises world-class scientists, clinicians, technologists, biotech/pharma and regulatory professionals from 40 countries focused on preclinical and translational aspects of developing cell therapy products. The International Society for Cellular Therapy has evolved in alignment with the maturation of the field of cell therapy and regenerative medicine to create forums for discussion of shared concerns for commercialization of cell therapies and of development of consensus standards, recognizing that true commercialization depends upon the translational scientific community, the regional regulatory and policy institutions, and the technology support and capital investment from industry. It exists to facilitate the international work of many, to spawn new initiatives, and to synergize with other stakeholders to create the best outcome for the many patients across the world depending on the answers and improved health that cellular therapeutics will provide them.

Original languageEnglish (US)
Pages (from-to)163-166
Number of pages4
JournalRegenerative Medicine
Volume6
Issue number2
DOIs
StatePublished - Mar 2011

Fingerprint

Regenerative Medicine
Cell- and Tissue-Based Therapy
Industry
Health
Investigational Therapies
Consensus
Therapeutics
Economics
Technology
Research

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Institutional Profile : The International Society for Cellular Therapy: Evolving to meet the demands of the regenerative medicine industry. / Maziarz, Richard; Arthurs, Jane; Horwitz, Edwin.

In: Regenerative Medicine, Vol. 6, No. 2, 03.2011, p. 163-166.

Research output: Contribution to journalArticle

@article{21b35d31a0664f7ea02df9cb578d42b3,
title = "Institutional Profile: The International Society for Cellular Therapy: Evolving to meet the demands of the regenerative medicine industry",
abstract = "The International Society for Cellular Therapy is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Established in 1992, its membership and leadership comprises world-class scientists, clinicians, technologists, biotech/pharma and regulatory professionals from 40 countries focused on preclinical and translational aspects of developing cell therapy products. The International Society for Cellular Therapy has evolved in alignment with the maturation of the field of cell therapy and regenerative medicine to create forums for discussion of shared concerns for commercialization of cell therapies and of development of consensus standards, recognizing that true commercialization depends upon the translational scientific community, the regional regulatory and policy institutions, and the technology support and capital investment from industry. It exists to facilitate the international work of many, to spawn new initiatives, and to synergize with other stakeholders to create the best outcome for the many patients across the world depending on the answers and improved health that cellular therapeutics will provide them.",
author = "Richard Maziarz and Jane Arthurs and Edwin Horwitz",
year = "2011",
month = "3",
doi = "10.2217/rme.10.102",
language = "English (US)",
volume = "6",
pages = "163--166",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Institutional Profile

T2 - The International Society for Cellular Therapy: Evolving to meet the demands of the regenerative medicine industry

AU - Maziarz, Richard

AU - Arthurs, Jane

AU - Horwitz, Edwin

PY - 2011/3

Y1 - 2011/3

N2 - The International Society for Cellular Therapy is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Established in 1992, its membership and leadership comprises world-class scientists, clinicians, technologists, biotech/pharma and regulatory professionals from 40 countries focused on preclinical and translational aspects of developing cell therapy products. The International Society for Cellular Therapy has evolved in alignment with the maturation of the field of cell therapy and regenerative medicine to create forums for discussion of shared concerns for commercialization of cell therapies and of development of consensus standards, recognizing that true commercialization depends upon the translational scientific community, the regional regulatory and policy institutions, and the technology support and capital investment from industry. It exists to facilitate the international work of many, to spawn new initiatives, and to synergize with other stakeholders to create the best outcome for the many patients across the world depending on the answers and improved health that cellular therapeutics will provide them.

AB - The International Society for Cellular Therapy is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Established in 1992, its membership and leadership comprises world-class scientists, clinicians, technologists, biotech/pharma and regulatory professionals from 40 countries focused on preclinical and translational aspects of developing cell therapy products. The International Society for Cellular Therapy has evolved in alignment with the maturation of the field of cell therapy and regenerative medicine to create forums for discussion of shared concerns for commercialization of cell therapies and of development of consensus standards, recognizing that true commercialization depends upon the translational scientific community, the regional regulatory and policy institutions, and the technology support and capital investment from industry. It exists to facilitate the international work of many, to spawn new initiatives, and to synergize with other stakeholders to create the best outcome for the many patients across the world depending on the answers and improved health that cellular therapeutics will provide them.

UR - http://www.scopus.com/inward/record.url?scp=79952601886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952601886&partnerID=8YFLogxK

U2 - 10.2217/rme.10.102

DO - 10.2217/rme.10.102

M3 - Article

VL - 6

SP - 163

EP - 166

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 2

ER -